文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

体外生命支持治疗实验性缺血性长时间心脏骤停:高与低血压目标比较

High Versus Low Blood-Pressure Target in Experimental Ischemic Prolonged Cardiac Arrest Treated with Extra Corporeal Life Support.
PubMed 文献 · Shock · 2017-01-01
一句话结论在实验性ECPR模型中,ECLS启动后最初数小时将平均动脉压目标设为80–85 mmHg与65–70 mmHg相比,未带来血流动力学改善,也未减少输液量。

本研究为随机动物实验,14头雄性猪通过手术结扎室间冠状动脉诱发心室颤动,心肺复苏20分钟后启动体外生命支持(ECLS)恢复循环。随后动物随机分为高平均动脉压组(High-MAP,80–85 mmHg)和标准平均动脉压组(Standard-MAP,65–70 mmHg)。在基线、ECLS启动即刻及启动后6小时评估乳酸变化、输液量和微循环参数。结果显示两组在ECLS启动时和6小时乳酸水平无显著差异(启动时High-MAP vs Standard-MAP:8.8 [6.7–12.9] vs 9.6 [9.1–9.8] mmol·l,P=0.779;6小时:8.9 [4.3–11.1] vs 3.3 [2.4–11] mmol·l,P=0.603),输液量无显著差异(4,000 [3,500–12,000] vs 5,000 [2,500–18,000] mL,P=0.977),肾功能、肝功能及舌下毛细血管微血管流指数(Sidestream Dark Field成像评估)亦无显著差异。结论认为,与标准平均动脉压方案相比,在实验性ECPR模型最初数小时 targeting 高平均动脉压未带来任何血流动力学改善,也未减少输液量。

要点

  • 在实验性ECPR模型中,ECLS启动后最初数小时高MAP目标(80–85 mmHg)与标准MAP目标(65–70 mmHg)相比,6小时乳酸水平无显著差异(8.9 [4.3–11.1] vs 3.3 [2.4–11] mmol·l,P=0.603)。
  • 两组输液量无显著差异(High-MAP 4,000 [3,500–12,000] mL vs Standard-MAP 5,000 [2,500–18,000] mL,P=0.977)。
  • 两组肾功能、肝功能及舌下毛细血管微血管流指数(Sidestream Dark Field成像)均无显著差异。
  • 作者结论:在实验性ECPR模型最初数小时,与标准MAP方案相比,高MAP目标未带来血流动力学改善,也未减少输液量。

适用人群与场景

  • 实验性ECPR模型:14头雄性猪,通过手术结扎室间冠状动脉诱发心室颤动,心肺复苏20分钟后启动ECLS恢复循环。

处置流程与药物剂量

  • ECLS启动后,动物随机分入高平均动脉压组(High-MAP,目标80–85 mmHg)或标准平均动脉压组(Standard-MAP,目标65–70 mmHg)。

研究设计与关键结果

  • 研究类型:随机动物实验;样本量:14头雄性猪;设置:大学研究实验室。
  • 干预:心室颤动诱发后心肺复苏20分钟,启动ECLS恢复循环,随后随机分为High-MAP组(80–85 mmHg)与Standard-MAP组(65–70 mmHg)。
  • 主要终点结果:ECLS启动时乳酸水平High-MAP vs Standard-MAP为8.8 [6.7–12.9] vs 9.6 [9.1–9.8] mmol·l,P=0.779;启动后6小时为8.9 [4.3–11.1] vs 3.3 [2.4–11] mmol·l,P=0.603,两组无显著差异。
  • 关键次要终点:输液量High-MAP vs Standard-MAP为4,000 [3,500–12,000] vs 5,000 [2,500–18,000] mL,P=0.977,无显著差异;肾功能、肝功能及舌下毛细血管微血管流指数(Sidestream Dark Field成像)两组亦无显著差异。

证据类型、等级与局限

  • 证据类型:随机动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在实验性ECPR模型中,ECLS启动后最初数小时将MAP目标设为80–85 mmHg与65–70 mmHg相比,未显示血流动力学改善或输液量减少;作者认为该结果不支持在实验性ECPR模型最初数小时追求高MAP目标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is currently no recommendation for the mean arterial pressure target in the particular setting of Extracorporeal Cardiopulmonary Resuscitation (ECPR) in the first hours following cardiogenic shock complicated by cardiac arrest. This study aimed to assess the effects of two different levels of mean arterial pressure on macrocirculatory, microcirculatory, and metabolic functions.

DESIGN: Randomized animal study.

SETTING: University research laboratory.

INTERVENTION: Ventricular fibrillation was induced in 14 male pigs by surgical ligature of the interventricular coronary artery. After 20 min of cardiopulmonary resuscitation, Extracorporeal Life Support (ECLS) was initiated to restore circulatory flow. Thereafter, animals were randomly allocated to a high mean arterial pressure group (High-MAP, 80-85 mm Hg) or to a standard mean arterial pressure group (Standard-MAP, 65-70 mm Hg). Assessments conducted at baseline, immediately following and 6 h after ECLS initiation were focused on lactate evolution, amount of infused fluid, and microcirculatory parameters.

RESULTS: There was no significant difference between the two groups at the time of ECLS initiation and at 6 h with regard to lactate levels (High-MAP vs. Standard-MAP: 8.8 [6.7-12.9] vs. 9.6 [9.1-9.8] mmol·l, P = 0.779 and 8.9 [4.3-11.1] vs. 3.3 [2.4-11] mmol·l, P = 0.603). Infused fluid volume did not significantly differ between the two groups (4,000 [3,500-12,000] vs. 5,000 [2,500-18,000] mL, P = 0.977). There was also no significant difference between the two groups regarding renal and liver functions, and sublingual capillary microvascular flow index assessed by Sidestream Dark Field imaging.

CONCLUSION: Compared with a standard mean arterial pressure regimen, targeting a high mean arterial pressure in the first hours of an experimental ECPR model did not result in any hemodynamic improvement nor in a decrease in the amount of infused fluid.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Fritz C, Kimmoun A, Vanhuyse F, et al. High Versus Low Blood-Pressure Target in Experimental Ischemic Prolonged Cardiac Arrest Treated with Extra Corporeal Life Support. Shock. 2017. PMID: 27841847. doi:10.1097/SHK.0000000000000793

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。